THE HUMBOLDT PREHARVEST DEP REPORT 2023

For many cannabis enthusiasts, the first real wave of the year’s harvest starts with the light-deprivation-style grown cannabis that comes down each June. 

The resulting cannabis is often shortened to deps by industry folks. They’re produced by farmers using various means to control the light cycle to force plants to flower. They started to become prevalent in the mid-2000s. For many years a lot of people just used the early dep harvests to pay their trimmers in the fall when their full-term harvest came down. But the quality of the product saw the prevalence of the cultivation style continues to grow to this day, where many expect solid deps to be a big part of the forthcoming national marketplace. 

When it comes to deps, Humboldt County is one of the best places in the world to find the best representations of various strains grown that way. In the years The Emerald Triangle’s farms weren’t decimated by fire and smoke, it basically seemed impossible to grow better deps than the cream of the crop coming out of Humboldt’s hills annually. 

But as opposed to smoke, this year’s early season saw farmers dealing with a lot of overcast skies as the heavens opened up to pour water on California. The Vesuvio Gardens team told us there was basically no spring this year and that led to many people getting a later start than usual. Vesuvio was a couple of weeks into flower when we chatted with them.

“We’re only about 10 days behind in Honeydew, and in Whitehorn, we’re pretty much on schedule,” Vesuvio’s founder Joe Jacovini told L.A. Weekly. He went on to note the early runs don’t do so well in Humboldt’s valleys, as opposed to the hilltops where they can get a lot of light. 

One of Humboldt’s most prominent dep cultivators is Jason Gellman of Ridgeline Farms. Ridgeline returned to the top of The Emerald Cup podium this year after previously winning back-to-back editions of one of the most coveted prizes in cannabis. With the exception of a few full-sun plants he does for personal use, Gellman is exclusively growing sungrown deps. He does partner at another light-assisted facility in the winter. 

We asked Gellman how the scene up north was looking, as he preps for the 2023 harvest to begin. 

“We know we hear the prices are going up, I hear that a lot, but nobody has herb,” Gellman told L.A. Weekly. “Does that mean it’s going to really go up? Because usually when you get the herb, then where are all the buyers, but I feel like right now, this should be a good year. I know there’s a pretty big drought of good-quality weed right now.”

We asked Gellman if the trophy shelf makes it easier for him to get top dollar against the rest of the harvest. 

“I always hear that a lot of the time and everyone thinks because I got a name and a brand, they think I can get more than X guy and it’s really not the case,” Gellman replied. “I mean you spend so much money packaging and prerolls and everything like that, it’s really hard. The people who wholesale their weed probably make more money than I do at the end of day.” 

Despite the perils of packaging as he listens to the numbers start to fly around the bulk product, he’s excited for the weeks ahead. 

“I think it’s going to be decent. It really depends on the weather. We’ve had unstable weather so far. For this first round. We didn’t have sun for three days straight. And so if we don’t get heat, we got small bud and that’s going to really affect the quality of the whole dep harvest around here on round one. So we’re playing with the weather, and we’re hoping that it’s shifting, it’s a little more scalable, and I think it’s gonna be a good year.”

After going through the struggles of the past few years, 2023 is looking daily upbeat for Ridgeline. 

“I think for the people that have hung in there are gonna get rewarded, be able to make a living and I mean that’s what it’s all about right now. Just trying to stay alive, make a living and keep our jobs,” Gellman said. 

Photo: Molly Keesling

WOMEN IN CANNABIS REMEMBER BROWNIE MARY 

For this week’s Women in Business issue, we reached out to the ladies of the cannabis industry to see what Mary Jane Rathbun, more famously known as Brownie Mary, means to them. 

While Brownie Mary was most famously an activist providing thousands of brownies for San Francisco’s AIDS community in the 1980s and 1990s, it is important not to disenfranchise the fact she was one of the early female entrepreneurs of the game, too. After decades as a waitress, she started selling brownies in the 1970s to make an extra buck. She would go on to help a lot of people, too, but for the sake of this piece we were celebrating the business side of things. 

These days, Lauren McNaughton is the director of brand marketing for Kiva and Lost Farms. In a past life, she helped build one of the largest infused baked goods companies California will ever see, Korova. McNaughton spent the tail end of the 215 era delivering boxes of cookies and brownies out of her trunk and being the boots on the ground for arguably the most bang-for-the-buck edible company ever in California.

“She was a beacon of compassion, activism and heroism,” McNaughton said of Brownie Mary. “Foundational to Prop 215, Brownie Mary represents the entirety of what built this “industry.” Compassionate care, not for profit. Not to mention the roads she paved for women in the industry. What an incredible influence to help guide us on this ever-changing landscape. And don’t get me started on what she meant to me when the beginning of my cannabis career was literally serving up brownies out of the trunk of my car.”

Cara Cordoni is the host of Dirty Bong Talk. She was also very connected with many of Rathbun’s surviving friends before she made the move to Humboldt from San Francisco. She spent countless hours with Brownie Mary’s peers from the fight for Proposition 215.

“Loudmouth for love, that’s one way I think about Mary Rathburn,” Cordoni said. “I love that she swore like a sailor! And my heart always aches when I think about her losing her only child, and then years later calling all her patients ‘her kids,’ mostly young men dying with AIDS, many of whom had been abandoned by their families. Compassion in action.”

Cordoni noted that as much as we celebrate Brownie Mary and as much as she was respected during her life, her end days sounded sad. 

“The last bit that haunts me, and I’d be curious to find out if it’s true, is that it’s widely understood that she actually died alone. That she ended up in the hospital and her friends didn’t know. I hope that is not factual.” Cordoni said, 

Jeany Zhou, the buyer and assistant manager at Berner’s on Haight, noted the San Francisco and then wider industry adopted her idea of compassion at The Hemp Center and donated cannabis to those who needed it.

Zhou went on to note, “The Brownie Mary Democrat Club is very active in the community and best represents her name; lobbying for safe cannabis access, shaping cannabis regulations, and educating the importance of cannabis and its properties.”

One of the greatest honors she has had since her passing was having the restoration of compassion programs in the age of legalization. The Dennis Peron and Brownie Mary Act was signed by Governor Gavin Newsom in 2019. It created a mechanism for dispensaries to legally give away product to sick people without having to pay a bunch of extra taxes.

The act has now facilitated millions of dollars worth of medicine being distributed to California’s low-income population that need help affording it in the years since it passed. 

Photo: Andy Feliciotti

ADVOCATES WANT CANNABIS DESCHEDULED NOT RESCHEDULED

Last week’s leaked letter from the Department of Health and Human Services (HHS) recommending that the U.S. Drug Enforcement Administration (DEA) reclassify cannabis from a Schedule I to a Schedule III controlled substance under federal law was lacking for advocates who want to see it descheduled. 

All of the OG cannabis reformers are weighing in. Congressman Earl Blumenauer has been involved in cannabis reform for 50 years. He founded the Congressional Cannabis Caucus in 2017. 

“This is a step in the right direction, but it is not sufficient. I hope it is followed by more significant reforms,” Blumenauer said. “This is long overdue.”

Blumenauer noted he pushed the Biden Administration to deschedule marijuana last December. Later in the spring, he called for more transparency in the wider Controlled Substances Act scheduling process. 

NORML, the nation’s oldest marijuana reform organization, noted the DEA said as recently as 2016, cannabis had no current accepted medical use regardless of all the babies with Dravet’s Syndrome that started the CBD explosion making national headlines for years at that point. The DEA will have the final say in all of this; we know how it went the last four times. 

NORML’s deputy director and longtime policy ninja, Paul Armentano, weighed in on the letter.

“It will be very interesting to see how DEA responds to this recommendation, given the agency’s historic opposition to any potential change in cannabis’ categorization under federal law,”  Armentano said. “Further, for decades, the agency has utilized its own five-factor criteria for assessing cannabis’ placement in the CSA — criteria that as recently as 2016, the agency claimed that cannabis failed to meet. Since the agency has final say over any rescheduling decision, it is safe to say that this process still remains far from over.”

Like Blumenauer, NORML has been calling for cannabis to be removed from the Controlled Substances Act for years. They recommend doing it in a manner that’s similar to liquor and tobacco. 

“The goal of any federal cannabis policy reform ought to be to address the existing, untenable chasm between federal marijuana policy and the cannabis laws of the majority of US states,” Armentano said. “Rescheduling the cannabis plant to Schedule III of the US Controlled Substances Act fails to adequately address this conflict, as existing state legalization laws — both adult use and medical — will continue to be in conflict with federal regulations, thereby perpetuating the existing divide between state and federal marijuana policies.”

Armentano closed, noting it’s the same level of intellectual dishonesty to categorize cannabis next to anabolic steroids as it is in its current situation on the list next to heroin.

With the US recreational cannabis market worth more than ever, it would seem something is going to have to be done to remedy the situation. Last week, California announced it had taken in just over $5 billion since the legal market kicked off in 2018, New York City’s first shop did $12 million in its first six months, and there are about 50 more data points off the top of my head why states aren’t going to let this fly. 

In the end, descheduling is likely. But the road is going to be a bit longer. And you can expect it to be the result of a future Congress and White House taking some kind of mandated action that the DEA won’t have a say in. 

Photo: Maria Oswalt

CURE ACT WOULD OPEN FED JOBS TO FORMER POT SMOKERS

The House Oversight and Accountability Committee moved forward with a bill that would expand federal employment opportunities for people who used cannabis at some point in their lives.

The Cannabis Users’ Restoration of Eligibility Act passed the committee in a 30-14 vote. It would allow federal agencies to consider applicants with a prior history of cannabis use when they are making employment and security clearance decisions. 

NORML, the nation’s oldest cannabis reform organization, praised the move by Congress. 

“Applicants for federal employment and security clearances should not be unfairly disqualified solely for their past cannabis use,” NORML’s Political Director Morgan Fox said. “While it is disappointing that the committee did not see fit to stop federal agencies from discriminating against those responsible adults and patients who are current consumers of cannabis, this legislation will nonetheless open up new opportunities to millions of Americans, increase the talent pool available to federal employers, and ultimately make our country safer.”

Fox went on to note many agencies are already reducing the impact cannabis use has on their hiring processes. 

“The Office of Personnel Management has similarly recommended that all federal agencies limit the window of time during which one’s past cannabis use is considered for denial of employment,” Fox said. “And a growing number of states are taking steps to protect the employment rights of responsible cannabis consumers and increase the opportunities available to them. Congress should do the same, and this overwhelming bipartisan vote today shows that lawmakers on both sides of the aisle are moving in the right direction.”

After the FBI loosened its policy on marijuana smokers in the summer of 2021, it famously said that smoking marijuana more than 24 times would disqualify potential candidates. As Marijuana Moment noted at the time, there was no explanation of how the FBI got to that number. Use prior to someone’s 18th birthday would not disqualify them, so you had to have broken the law 24 times as an adult. 

The concept of opening the door for more people with a history of cannabis use is nothing new, but a decade ago in the months after Colorado and Washington kicked off our grand legalization experiment, it was a little “too soon” for some lawmakers. Then FBI Director James Comey joked to Congress that the amount of people who smoke weed these days is making the hiring process a bit trickier for the nation’s chief law enforcement agency, 

“I have to hire a great workforce to compete with those cyber criminals and some of those kids want to smoke weed on the way to the interview,” Comey said at the time according to The Wall Street Journal. 

While still a senator, Jeff Sessions got mad at Comey claiming his words could be construed as something supportive of cannabis use. Comey clapped back that was certainly not the case, but his hiring reality, and he was determined to not lose his sense of humor regardless of how serious a job it is to run the FBI. 

Gallup noted in 2021 nearly half of all Americans have smoked marijuana at some point in their lives. It seems like preventing half the population from getting a government job is absolutely madness. As more and more states move forward with legalization, it will become even more unsustainable to prevent our best and brightest from serving their country in some capacity because they smoked a little bit of cannabis. 

Hopefully, the CURE Act will continue on its path through Congress and onto the president’s desk, to give these people a shot at doing whatever they see fit in service to the rest of us. 

Courtesy of NASA

Hash Holes Go to Mars With Jiko+

Jimi Devine August 18, 2023 Cannabis

Can tech-backed oversupply ruin clout? We’re about to find out with the new Jiko+ Donut Maker designed by a former NASA engineer.

The creators of the Jiko+ are looking to conquer one of the points in the cannabis supply chain people have not been able to automate up to this point. Sure there have been infused preroll machines, but they were never a true donut, or as we call them now, hash hole. The tech attached to those machines was mostly needles attached to a heating element that would shoot the concentrate into each joint evenly as it removed the needle. A lot of the time the material being used in these infused prerolls, both the flower and hash, was between garbage and subpar.

On many occasions, those infused prerolls were simply an attempt to bump the price of their contents by trying to make them sound nicer. These kinds of preroll entities have existed since the early 2010s because, for every more educated connoisseur that knew they were garbage, there were a few part-time puffers that knew they wanted to get “messed up.” Add to that the fact prerolls have continued to grow their market share as a whole in the years since legalization and it’s easy to see why there are some shady folks that remain commercially viable.  

There is an argument to be made that darkness before the light partially helped rocket hash holes into the stratosphere. We were so used to how bad it had gotten with infused prerolls that when we finally started seeing small batch artisan hash holes after Fidel brought the premise back from Barcelona, it was like a hype lightning storm that came out of nowhere. Overnight, the most expensive prerolls in the state were hand-rolled small-batch prerolls filled with exotic rosins and equally high-end flowers. 

Since hash holes came out the gate so strong, it was easy to see who was skimping on quality. To this point, they’ve remained a daily boutique thing. 

When I asked Fidel what he thought of something like the Jiko+, he simply replied wondering why someone would need to roll 800 hash holes in an hour. What will the top-shelf preroll market turn into?

Or, will the hardware truly even be able to compare to Calirofnia’s best rollers? You could even say the hash hole hype helped breathe this new generation of famous rollers that took off after the pandemic. The Brunos, the CGOs, and others who have conquered the space, are turning into legit cannabis celebrities and influencers around the world. When I was at Hash Hole Island earlier this week up north outside Sacramento, I met people from Texas and New York that just flew in to smoke hash holes. The last time I was in Africa, I saw Bruno’s star power firsthand as some of the local hitters were simply giddy to see him. Can a machine recreate this kind of culture?

I don’t know. But once you get past the philosophical questions about maintaining the boutique aspect of hash holes, the Jiko+ is admittedly pretty dope. It accommodates various joint and blunt sizes that range from one to three grams. The amount of hash inside of each range from .2 to a full gram. 

“Up until now, crafting these intricate, infused prerolls by hand required labor-intensive processes that lacked scalability, consistency and dependability. We’re proud to have developed the technology and equipment that both brands and consumers will appreciate and enjoy,” says Nohtal Partansky, co-founder and CEO of Sorting Robotics.

Partansky is a former engineer at NASA’s Jet Propulsion Laboratory in Pasadena. While there, he worked on the MOXIE project. That instrument is currently on the surface of Mars producing oxygen from the Martian atmosphere. That kind of hardware is obviously critical for any future exploration of the red planet. 

Advertising disclosure: We may receive compensation for some of the links in our stories. Thank you for supporting LA Weekly and our advertisers.

AMERICAN CANNABIS INDUSTRY NEARS $30 BILLION VALUE

The latest forecast from the data crunchers at BDSA has the U.S. cannabis industry growing to just south of $30 billion by the end of the year. 

Globally, they project the industry to be worth $36.7 billion in 2023 with roughly 80%, or $29.6 billion, of sales coming from the U.S. state markets. BDSA is expecting the global marketplace to grow about 13% a year through 2027. The U.S. market is expected to be worth $45 billion by that time. 

“Over the next five years, the biggest drivers of cannabis industry growth in the U.S. will be the thriving Midwest and East Coast markets,” said Roy Bingham, co-founder and CEO of BDSA. “New markets, especially adult-use markets like Missouri, New Jersey and New York, will lead growth. Although mature Western markets such as Colorado and California have experienced sales stagnation or decline due to price compression, they will continue to account for a substantial portion of legal sales through 2027.”  

BDSA went on to cover some of the key numbers that will be playing into the growth. This includes the new Missouri market, which is expected to do $1.4 billion in sales this year. BDSA expects New York to do about $631 million this year but jump to $2.5 billion by 2027. New York sales are projected to see an annual compound growth rate of roughly 71%. 

Then there are the markets that haven’t come online yet, even hypothetical ones like Florida play into the number where BDSA is expecting sales to start in 2025 and have a value of $4.3 billion per year by 2027. Minnesota, which legalized adult-use cannabis last month, will begin sales next year and is expected to do $117 million in sales next year and grow to $875 million by 2027. 

The growth of midwestern cannabis markets is going well. Illinois is projected to do $2 billion in sales this year. Michigan has seen sales bump 19% in 2023 and the market is expected to be worth $3.5 Billion by 2027. 

BDSA went on to note that here in California, the numbers are being impacted by the price of the pound crashing and the fact the illicit market still dwarfs the legal one. BDSA argues these are the main reasons California’s legal market saw a decline in sales for the first time in 2022. The report notes that based on the sales in the first quarter of 2023, the California market is expected to decline by 9% this year. 

“California cannabis price compression emerged as a result of ongoing competition from the well-established illicit channel, and an oversupply of cannabis products as cultivation has ramped up in the legal channel since the start of adult-use sales in 2018,” Bingham told L.A. Weekly in an email. “This led to a decline in average retail prices beginning in Q3 2021. BDSA Retail Sales Tracking data show that equivalent average retail prices in California declined 21% between Q3 2021 and Q1 2023. Other mature markets, such as Michigan, have grown in total dollar sales despite price compression, but unit sales growth in California has not been strong enough to counteract price declines.” 

Bingham went on to cover some of the positives that came out of the storm of 2022. 

“While consumers benefited from more affordable cannabis, industry players had to adapt by optimizing operations and focusing on quality and brand reputation,” Bingham said. “The experience highlighted the need for strategic planning and a balanced regulatory framework in the evolving cannabis industry.”

Even with the decline in sales, California is still expected to represent a massive chunk of the U.S. cannabis industry for the foreseeable future.